nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—breast cancer—Estradiol valerate/Dienogest—prostate cancer	0.145	0.245	CpDpCtD
Prochlorperazine—breast cancer—Estrone—prostate cancer	0.145	0.245	CpDpCtD
Prochlorperazine—breast cancer—Estradiol—prostate cancer	0.11	0.185	CpDpCtD
Prochlorperazine—breast cancer—Conjugated Estrogens—prostate cancer	0.11	0.185	CpDpCtD
Prochlorperazine—CYP3A4—prostate cancer	0.09	1	CbGaD
Prochlorperazine—breast cancer—Ethinyl Estradiol—prostate cancer	0.083	0.14	CpDpCtD
Prochlorperazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0285	0.154	CbGbCtD
Prochlorperazine—CYP2D6—Bicalutamide—prostate cancer	0.0236	0.128	CbGbCtD
Prochlorperazine—CYP2D6—Abiraterone—prostate cancer	0.0195	0.106	CbGbCtD
Prochlorperazine—CYP3A4—Bicalutamide—prostate cancer	0.015	0.0811	CbGbCtD
Prochlorperazine—CYP3A4—Estramustine—prostate cancer	0.0139	0.0754	CbGbCtD
Prochlorperazine—CYP3A4—Abiraterone—prostate cancer	0.0124	0.0672	CbGbCtD
Prochlorperazine—CYP3A4—Flutamide—prostate cancer	0.0124	0.0672	CbGbCtD
Prochlorperazine—CYP3A4—Cabazitaxel—prostate cancer	0.00918	0.0497	CbGbCtD
Prochlorperazine—CYP3A4—Estrone—prostate cancer	0.00898	0.0486	CbGbCtD
Prochlorperazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.008	0.0433	CbGbCtD
Prochlorperazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00587	0.0318	CbGbCtD
Prochlorperazine—CYP3A4—Mitoxantrone—prostate cancer	0.00534	0.0289	CbGbCtD
Prochlorperazine—CYP3A4—Estradiol—prostate cancer	0.00516	0.0279	CbGbCtD
Prochlorperazine—CYP3A4—Prednisone—prostate cancer	0.00443	0.024	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—prostate cancer	0.00361	0.0196	CbGbCtD
Prochlorperazine—CYP3A4—Etoposide—prostate cancer	0.00337	0.0182	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—prostate cancer	0.00308	0.0167	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—prostate cancer	0.0023	0.0124	CbGbCtD
Prochlorperazine—Cyclizine—SULT1E1—prostate cancer	0.000468	0.174	CrCbGaD
Prochlorperazine—Perphenazine—AOX1—prostate cancer	0.000129	0.048	CrCbGaD
Prochlorperazine—Clobazam—CYP2C18—prostate cancer	8.47e-05	0.0314	CrCbGaD
Prochlorperazine—Domperidone—CYP3A5—prostate cancer	7.75e-05	0.0287	CrCbGaD
Prochlorperazine—Photosensitivity—Epirubicin—prostate cancer	7.23e-05	0.000771	CcSEcCtD
Prochlorperazine—Acepromazine—SLC22A1—prostate cancer	7.19e-05	0.0267	CrCbGaD
Prochlorperazine—Urticaria—Goserelin—prostate cancer	7.19e-05	0.000768	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Capecitabine—prostate cancer	7.18e-05	0.000767	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Estradiol—prostate cancer	7.18e-05	0.000766	CcSEcCtD
Prochlorperazine—Oedema—Estradiol—prostate cancer	7.18e-05	0.000766	CcSEcCtD
Prochlorperazine—Weight increased—Capecitabine—prostate cancer	7.16e-05	0.000765	CcSEcCtD
Prochlorperazine—Body temperature increased—Goserelin—prostate cancer	7.16e-05	0.000764	CcSEcCtD
Prochlorperazine—Cough—Mitoxantrone—prostate cancer	7.15e-05	0.000763	CcSEcCtD
Prochlorperazine—Infection—Estradiol—prostate cancer	7.13e-05	0.000761	CcSEcCtD
Prochlorperazine—Urticaria—Conjugated Estrogens—prostate cancer	7.12e-05	0.00076	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Capecitabine—prostate cancer	7.1e-05	0.000758	CcSEcCtD
Prochlorperazine—Convulsion—Mitoxantrone—prostate cancer	7.1e-05	0.000758	CcSEcCtD
Prochlorperazine—Body temperature increased—Conjugated Estrogens—prostate cancer	7.09e-05	0.000757	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—prostate cancer	7.07e-05	0.000754	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—prostate cancer	7.06e-05	0.000753	CcSEcCtD
Prochlorperazine—Thioproperazine—SLC22A1—prostate cancer	7.03e-05	0.0261	CrCbGaD
Prochlorperazine—Skin disorder—Estradiol—prostate cancer	6.97e-05	0.000744	CcSEcCtD
Prochlorperazine—Rash—Ethinyl Estradiol—prostate cancer	6.94e-05	0.00074	CcSEcCtD
Prochlorperazine—Dermatitis—Ethinyl Estradiol—prostate cancer	6.93e-05	0.00074	CcSEcCtD
Prochlorperazine—Thiothixene—SLC22A1—prostate cancer	6.92e-05	0.0256	CrCbGaD
Prochlorperazine—Pipotiazine—SLC22A1—prostate cancer	6.92e-05	0.0256	CrCbGaD
Prochlorperazine—Headache—Ethinyl Estradiol—prostate cancer	6.89e-05	0.000736	CcSEcCtD
Prochlorperazine—Jaundice—Capecitabine—prostate cancer	6.84e-05	0.00073	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—prostate cancer	6.76e-05	0.000722	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—prostate cancer	6.75e-05	0.000721	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—prostate cancer	6.72e-05	0.000718	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Mitoxantrone—prostate cancer	6.69e-05	0.000714	CcSEcCtD
Prochlorperazine—Oedema—Mitoxantrone—prostate cancer	6.69e-05	0.000714	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—prostate cancer	6.69e-05	0.000714	CcSEcCtD
Prochlorperazine—Hypersensitivity—Goserelin—prostate cancer	6.67e-05	0.000712	CcSEcCtD
Prochlorperazine—Infection—Mitoxantrone—prostate cancer	6.64e-05	0.000709	CcSEcCtD
Prochlorperazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	6.61e-05	0.000705	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—prostate cancer	6.56e-05	0.0007	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—prostate cancer	6.55e-05	0.000699	CcSEcCtD
Prochlorperazine—Agranulocytosis—Capecitabine—prostate cancer	6.55e-05	0.000699	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mitoxantrone—prostate cancer	6.55e-05	0.000699	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—prostate cancer	6.53e-05	0.000697	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—prostate cancer	6.5e-05	0.000694	CcSEcCtD
Prochlorperazine—Skin disorder—Mitoxantrone—prostate cancer	6.5e-05	0.000693	CcSEcCtD
Prochlorperazine—Insomnia—Estradiol—prostate cancer	6.49e-05	0.000693	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Prednisone—prostate cancer	6.46e-05	0.000689	CcSEcCtD
Prochlorperazine—Nefazodone—CYP3A5—prostate cancer	6.44e-05	0.0239	CrCbGaD
Prochlorperazine—Oedema peripheral—Docetaxel—prostate cancer	6.41e-05	0.000684	CcSEcCtD
Prochlorperazine—Pruritus—Goserelin—prostate cancer	6.41e-05	0.000684	CcSEcCtD
Prochlorperazine—Dyspnoea—Estradiol—prostate cancer	6.4e-05	0.000683	CcSEcCtD
Prochlorperazine—Somnolence—Estradiol—prostate cancer	6.38e-05	0.000681	CcSEcCtD
Prochlorperazine—Weight increased—Prednisone—prostate cancer	6.38e-05	0.000681	CcSEcCtD
Prochlorperazine—Pruritus—Conjugated Estrogens—prostate cancer	6.34e-05	0.000677	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Prednisone—prostate cancer	6.32e-05	0.000675	CcSEcCtD
Prochlorperazine—Hypotension—Mitoxantrone—prostate cancer	6.25e-05	0.000667	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—prostate cancer	6.25e-05	0.000667	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—prostate cancer	6.22e-05	0.000664	CcSEcCtD
Prochlorperazine—Oedema peripheral—Capecitabine—prostate cancer	6.21e-05	0.000662	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—prostate cancer	6.15e-05	0.000657	CcSEcCtD
Prochlorperazine—Constipation—Estradiol—prostate cancer	6.14e-05	0.000655	CcSEcCtD
Prochlorperazine—Desipramine—SLC22A3—prostate cancer	6.13e-05	0.0227	CrCbGaD
Prochlorperazine—Leukopenia—Etoposide—prostate cancer	6.1e-05	0.000651	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—prostate cancer	6.07e-05	0.000647	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—prostate cancer	6.03e-05	0.000644	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—prostate cancer	6.02e-05	0.000642	CcSEcCtD
Prochlorperazine—Dizziness—Goserelin—prostate cancer	5.99e-05	0.000639	CcSEcCtD
Prochlorperazine—Aripiprazole—CYP3A5—prostate cancer	5.98e-05	0.0222	CrCbGaD
Prochlorperazine—Dyspnoea—Mitoxantrone—prostate cancer	5.96e-05	0.000636	CcSEcCtD
Prochlorperazine—Erythema multiforme—Capecitabine—prostate cancer	5.96e-05	0.000636	CcSEcCtD
Prochlorperazine—Trazodone—CYP3A5—prostate cancer	5.96e-05	0.0221	CrCbGaD
Prochlorperazine—Cough—Etoposide—prostate cancer	5.95e-05	0.000635	CcSEcCtD
Prochlorperazine—Somnolence—Mitoxantrone—prostate cancer	5.95e-05	0.000635	CcSEcCtD
Prochlorperazine—Dizziness—Conjugated Estrogens—prostate cancer	5.93e-05	0.000633	CcSEcCtD
Prochlorperazine—Clomipramine—GSTP1—prostate cancer	5.91e-05	0.0219	CrCbGaD
Prochlorperazine—Convulsion—Etoposide—prostate cancer	5.91e-05	0.00063	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—prostate cancer	5.81e-05	0.00062	CcSEcCtD
Prochlorperazine—Perphenazine—CYP2C18—prostate cancer	5.79e-05	0.0215	CrCbGaD
Prochlorperazine—Constipation—Mitoxantrone—prostate cancer	5.72e-05	0.00061	CcSEcCtD
Prochlorperazine—Rash—Goserelin—prostate cancer	5.71e-05	0.000609	CcSEcCtD
Prochlorperazine—Dermatitis—Goserelin—prostate cancer	5.7e-05	0.000609	CcSEcCtD
Prochlorperazine—Urticaria—Estradiol—prostate cancer	5.7e-05	0.000609	CcSEcCtD
Prochlorperazine—Body temperature increased—Estradiol—prostate cancer	5.67e-05	0.000606	CcSEcCtD
Prochlorperazine—Headache—Goserelin—prostate cancer	5.67e-05	0.000605	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—prostate cancer	5.66e-05	0.000605	CcSEcCtD
Prochlorperazine—Rash—Conjugated Estrogens—prostate cancer	5.65e-05	0.000603	CcSEcCtD
Prochlorperazine—Dermatitis—Conjugated Estrogens—prostate cancer	5.65e-05	0.000603	CcSEcCtD
Prochlorperazine—Arrhythmia—Capecitabine—prostate cancer	5.63e-05	0.000601	CcSEcCtD
Prochlorperazine—Headache—Conjugated Estrogens—prostate cancer	5.62e-05	0.0006	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—prostate cancer	5.58e-05	0.000596	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—prostate cancer	5.56e-05	0.000594	CcSEcCtD
Prochlorperazine—Infection—Etoposide—prostate cancer	5.53e-05	0.00059	CcSEcCtD
Prochlorperazine—Erythema—Capecitabine—prostate cancer	5.48e-05	0.000585	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—prostate cancer	5.48e-05	0.000585	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—prostate cancer	5.48e-05	0.000585	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—prostate cancer	5.48e-05	0.000585	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—prostate cancer	5.45e-05	0.000581	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—prostate cancer	5.45e-05	0.000581	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—prostate cancer	5.43e-05	0.000579	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—prostate cancer	5.4e-05	0.000577	CcSEcCtD
Prochlorperazine—Desipramine—CYP2C18—prostate cancer	5.39e-05	0.02	CrCbGaD
Prochlorperazine—Urticaria—Mitoxantrone—prostate cancer	5.31e-05	0.000567	CcSEcCtD
Prochlorperazine—Hypersensitivity—Estradiol—prostate cancer	5.29e-05	0.000564	CcSEcCtD
Prochlorperazine—Body temperature increased—Mitoxantrone—prostate cancer	5.29e-05	0.000564	CcSEcCtD
Prochlorperazine—Muscle spasms—Capecitabine—prostate cancer	5.27e-05	0.000563	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—prostate cancer	5.21e-05	0.000556	CcSEcCtD
Prochlorperazine—Imipramine—SLC22A3—prostate cancer	5.2e-05	0.0193	CrCbGaD
Prochlorperazine—Hypotension—Etoposide—prostate cancer	5.2e-05	0.000555	CcSEcCtD
Prochlorperazine—Vision blurred—Capecitabine—prostate cancer	5.17e-05	0.000552	CcSEcCtD
Prochlorperazine—Tremor—Capecitabine—prostate cancer	5.14e-05	0.000548	CcSEcCtD
Prochlorperazine—Pruritus—Estradiol—prostate cancer	5.08e-05	0.000542	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—prostate cancer	5.07e-05	0.000541	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—prostate cancer	5.07e-05	0.000541	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—prostate cancer	5.07e-05	0.000541	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—prostate cancer	5.07e-05	0.000541	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—prostate cancer	5.02e-05	0.000536	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisone—prostate cancer	5.01e-05	0.000535	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—prostate cancer	5.01e-05	0.000534	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—prostate cancer	4.99e-05	0.000533	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—prostate cancer	4.96e-05	0.000529	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—prostate cancer	4.95e-05	0.000528	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—prostate cancer	4.95e-05	0.000528	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—prostate cancer	4.94e-05	0.000528	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mitoxantrone—prostate cancer	4.93e-05	0.000526	CcSEcCtD
Prochlorperazine—Leukopenia—Capecitabine—prostate cancer	4.91e-05	0.000524	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—prostate cancer	4.91e-05	0.000524	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—prostate cancer	4.89e-05	0.000522	CcSEcCtD
Prochlorperazine—Erythema—Prednisone—prostate cancer	4.89e-05	0.000521	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—prostate cancer	4.82e-05	0.000514	CcSEcCtD
Prochlorperazine—Cough—Capecitabine—prostate cancer	4.79e-05	0.000511	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—prostate cancer	4.77e-05	0.000509	CcSEcCtD
Prochlorperazine—Constipation—Etoposide—prostate cancer	4.76e-05	0.000508	CcSEcCtD
Prochlorperazine—Dizziness—Estradiol—prostate cancer	4.75e-05	0.000507	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—prostate cancer	4.72e-05	0.000503	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—prostate cancer	4.63e-05	0.000494	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—prostate cancer	4.62e-05	0.000493	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—prostate cancer	4.62e-05	0.000493	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—prostate cancer	4.62e-05	0.000493	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisone—prostate cancer	4.6e-05	0.000491	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—prostate cancer	4.59e-05	0.00049	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—prostate cancer	4.58e-05	0.000488	CcSEcCtD
Prochlorperazine—Imipramine—CYP2C18—prostate cancer	4.57e-05	0.0169	CrCbGaD
Prochlorperazine—Dry mouth—Capecitabine—prostate cancer	4.57e-05	0.000487	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—prostate cancer	4.56e-05	0.000487	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—prostate cancer	4.53e-05	0.000483	CcSEcCtD
Prochlorperazine—Rash—Estradiol—prostate cancer	4.53e-05	0.000483	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—prostate cancer	4.52e-05	0.000483	CcSEcCtD
Prochlorperazine—Dermatitis—Estradiol—prostate cancer	4.52e-05	0.000483	CcSEcCtD
Prochlorperazine—Headache—Estradiol—prostate cancer	4.5e-05	0.00048	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—prostate cancer	4.49e-05	0.000479	CcSEcCtD
Prochlorperazine—Agitation—Prednisone—prostate cancer	4.49e-05	0.000479	CcSEcCtD
Prochlorperazine—Oedema—Capecitabine—prostate cancer	4.48e-05	0.000478	CcSEcCtD
Prochlorperazine—Angioedema—Prednisone—prostate cancer	4.46e-05	0.000476	CcSEcCtD
Prochlorperazine—Infection—Capecitabine—prostate cancer	4.45e-05	0.000475	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—prostate cancer	4.42e-05	0.000472	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—prostate cancer	4.41e-05	0.000471	CcSEcCtD
Prochlorperazine—Desipramine—SLC22A1—prostate cancer	4.4e-05	0.0163	CrCbGaD
Prochlorperazine—Body temperature increased—Etoposide—prostate cancer	4.4e-05	0.000469	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Capecitabine—prostate cancer	4.38e-05	0.000468	CcSEcCtD
Prochlorperazine—Skin disorder—Capecitabine—prostate cancer	4.35e-05	0.000464	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—prostate cancer	4.32e-05	0.000461	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—prostate cancer	4.32e-05	0.000461	CcSEcCtD
Prochlorperazine—Convulsion—Prednisone—prostate cancer	4.23e-05	0.000452	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—prostate cancer	4.22e-05	0.000451	CcSEcCtD
Prochlorperazine—Rash—Mitoxantrone—prostate cancer	4.22e-05	0.00045	CcSEcCtD
Prochlorperazine—Dermatitis—Mitoxantrone—prostate cancer	4.21e-05	0.00045	CcSEcCtD
Prochlorperazine—Headache—Mitoxantrone—prostate cancer	4.19e-05	0.000447	CcSEcCtD
Prochlorperazine—Hypotension—Capecitabine—prostate cancer	4.18e-05	0.000446	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—prostate cancer	4.18e-05	0.000446	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—prostate cancer	4.15e-05	0.000443	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—prostate cancer	4.12e-05	0.00044	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—prostate cancer	4.11e-05	0.000439	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—prostate cancer	4.1e-05	0.000437	CcSEcCtD
Prochlorperazine—Insomnia—Capecitabine—prostate cancer	4.05e-05	0.000432	CcSEcCtD
Prochlorperazine—Clozapine—CYP1B1—prostate cancer	4.04e-05	0.015	CrCbGaD
Prochlorperazine—Oedema peripheral—Doxorubicin—prostate cancer	4e-05	0.000427	CcSEcCtD
Prochlorperazine—Dyspnoea—Capecitabine—prostate cancer	3.99e-05	0.000426	CcSEcCtD
Prochlorperazine—Oedema—Prednisone—prostate cancer	3.99e-05	0.000426	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisone—prostate cancer	3.99e-05	0.000426	CcSEcCtD
Prochlorperazine—Infection—Prednisone—prostate cancer	3.96e-05	0.000423	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—prostate cancer	3.95e-05	0.000422	CcSEcCtD
Prochlorperazine—Alimemazine—CYP3A4—prostate cancer	3.95e-05	0.0146	CrCbGaD
Prochlorperazine—Pruritus—Etoposide—prostate cancer	3.94e-05	0.00042	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—prostate cancer	3.92e-05	0.000418	CcSEcCtD
Prochlorperazine—Skin disorder—Prednisone—prostate cancer	3.87e-05	0.000413	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—prostate cancer	3.84e-05	0.00041	CcSEcCtD
Prochlorperazine—Constipation—Capecitabine—prostate cancer	3.83e-05	0.000409	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—prostate cancer	3.82e-05	0.000408	CcSEcCtD
Prochlorperazine—Pipotiazine—CYP2C19—prostate cancer	3.8e-05	0.0141	CrCbGaD
Prochlorperazine—Clobazam—CYP2C19—prostate cancer	3.8e-05	0.0141	CrCbGaD
Prochlorperazine—Chlorpromazine—SLC22A1—prostate cancer	3.75e-05	0.0139	CrCbGaD
Prochlorperazine—Quetiapine—CYP3A5—prostate cancer	3.74e-05	0.0139	CrCbGaD
Prochlorperazine—Imipramine—SLC22A1—prostate cancer	3.73e-05	0.0138	CrCbGaD
Prochlorperazine—Nervousness—Epirubicin—prostate cancer	3.71e-05	0.000396	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—prostate cancer	3.68e-05	0.000393	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—prostate cancer	3.67e-05	0.000392	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—prostate cancer	3.65e-05	0.00039	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—prostate cancer	3.63e-05	0.000387	CcSEcCtD
Prochlorperazine—Insomnia—Prednisone—prostate cancer	3.61e-05	0.000385	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—prostate cancer	3.6e-05	0.000384	CcSEcCtD
Prochlorperazine—Urticaria—Capecitabine—prostate cancer	3.56e-05	0.000379	CcSEcCtD
Prochlorperazine—Body temperature increased—Capecitabine—prostate cancer	3.54e-05	0.000378	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—prostate cancer	3.54e-05	0.000377	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—prostate cancer	3.51e-05	0.000375	CcSEcCtD
Prochlorperazine—Rash—Etoposide—prostate cancer	3.51e-05	0.000374	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—prostate cancer	3.5e-05	0.000374	CcSEcCtD
Prochlorperazine—Headache—Etoposide—prostate cancer	3.48e-05	0.000372	CcSEcCtD
Prochlorperazine—Desipramine—CYP2A6—prostate cancer	3.44e-05	0.0127	CrCbGaD
Prochlorperazine—Nervousness—Doxorubicin—prostate cancer	3.43e-05	0.000366	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—prostate cancer	3.42e-05	0.000365	CcSEcCtD
Prochlorperazine—Constipation—Prednisone—prostate cancer	3.41e-05	0.000364	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—prostate cancer	3.41e-05	0.000364	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—prostate cancer	3.4e-05	0.000363	CcSEcCtD
Prochlorperazine—Mequitazine—CYP3A4—prostate cancer	3.4e-05	0.0126	CrCbGaD
Prochlorperazine—Domperidone—CYP3A4—prostate cancer	3.36e-05	0.0124	CrCbGaD
Prochlorperazine—Cough—Epirubicin—prostate cancer	3.33e-05	0.000356	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—prostate cancer	3.33e-05	0.000356	CcSEcCtD
Prochlorperazine—Fluphenazine—CYP2E1—prostate cancer	3.32e-05	0.0123	CrCbGaD
Prochlorperazine—Convulsion—Epirubicin—prostate cancer	3.31e-05	0.000353	CcSEcCtD
Prochlorperazine—Hypersensitivity—Capecitabine—prostate cancer	3.3e-05	0.000352	CcSEcCtD
Prochlorperazine—Pruritus—Docetaxel—prostate cancer	3.27e-05	0.000349	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—prostate cancer	3.25e-05	0.000347	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—prostate cancer	3.18e-05	0.00034	CcSEcCtD
Prochlorperazine—Urticaria—Prednisone—prostate cancer	3.17e-05	0.000338	CcSEcCtD
Prochlorperazine—Pruritus—Capecitabine—prostate cancer	3.17e-05	0.000338	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—prostate cancer	3.16e-05	0.000338	CcSEcCtD
Prochlorperazine—Body temperature increased—Prednisone—prostate cancer	3.15e-05	0.000336	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—prostate cancer	3.12e-05	0.000333	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—prostate cancer	3.12e-05	0.000333	CcSEcCtD
Prochlorperazine—Clozapine—CYP2A6—prostate cancer	3.11e-05	0.0115	CrCbGaD
Prochlorperazine—Infection—Epirubicin—prostate cancer	3.1e-05	0.000331	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—prostate cancer	3.08e-05	0.000329	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—prostate cancer	3.06e-05	0.000327	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—prostate cancer	3.06e-05	0.000326	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—prostate cancer	3.05e-05	0.000326	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—prostate cancer	3.03e-05	0.000323	CcSEcCtD
Prochlorperazine—Clomipramine—CYP2C19—prostate cancer	3e-05	0.0111	CrCbGaD
Prochlorperazine—Dizziness—Capecitabine—prostate cancer	2.96e-05	0.000316	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—prostate cancer	2.94e-05	0.000314	CcSEcCtD
Prochlorperazine—Hypersensitivity—Prednisone—prostate cancer	2.94e-05	0.000314	CcSEcCtD
Prochlorperazine—Rash—Docetaxel—prostate cancer	2.91e-05	0.000311	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—prostate cancer	2.91e-05	0.000311	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—prostate cancer	2.91e-05	0.000311	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—prostate cancer	2.9e-05	0.000309	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—prostate cancer	2.89e-05	0.000308	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—prostate cancer	2.89e-05	0.000308	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—prostate cancer	2.87e-05	0.000306	CcSEcCtD
Prochlorperazine—Thioridazine—CYP2E1—prostate cancer	2.86e-05	0.0106	CrCbGaD
Prochlorperazine—Thioridazine—CYP2C19—prostate cancer	2.83e-05	0.0105	CrCbGaD
Prochlorperazine—Thrombocytopenia—Doxorubicin—prostate cancer	2.82e-05	0.000301	CcSEcCtD
Prochlorperazine—Rash—Capecitabine—prostate cancer	2.82e-05	0.000301	CcSEcCtD
Prochlorperazine—Pruritus—Prednisone—prostate cancer	2.82e-05	0.000301	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—prostate cancer	2.82e-05	0.000301	CcSEcCtD
Prochlorperazine—Dermatitis—Capecitabine—prostate cancer	2.82e-05	0.000301	CcSEcCtD
Prochlorperazine—Desipramine—ADRB2—prostate cancer	2.81e-05	0.0104	CrCbGaD
Prochlorperazine—Headache—Capecitabine—prostate cancer	2.8e-05	0.000299	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—prostate cancer	2.8e-05	0.000299	CcSEcCtD
Prochlorperazine—Nefazodone—CYP3A4—prostate cancer	2.79e-05	0.0103	CrCbGaD
Prochlorperazine—Dyspnoea—Epirubicin—prostate cancer	2.78e-05	0.000297	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—prostate cancer	2.77e-05	0.000296	CcSEcCtD
Prochlorperazine—Methotrimeprazine—CYP2E1—prostate cancer	2.73e-05	0.0101	CrCbGaD
Prochlorperazine—Hypotension—Doxorubicin—prostate cancer	2.7e-05	0.000288	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—prostate cancer	2.67e-05	0.000285	CcSEcCtD
Prochlorperazine—Dizziness—Prednisone—prostate cancer	2.64e-05	0.000281	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—prostate cancer	2.61e-05	0.000279	CcSEcCtD
Prochlorperazine—Perphenazine—CYP2C19—prostate cancer	2.6e-05	0.00963	CrCbGaD
Prochlorperazine—Aripiprazole—CYP3A4—prostate cancer	2.59e-05	0.00961	CrCbGaD
Prochlorperazine—Trazodone—CYP3A4—prostate cancer	2.58e-05	0.00956	CrCbGaD
Prochlorperazine—Dyspnoea—Doxorubicin—prostate cancer	2.57e-05	0.000275	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—prostate cancer	2.57e-05	0.000274	CcSEcCtD
Prochlorperazine—Quetiapine—CYP2C19—prostate cancer	2.55e-05	0.00944	CrCbGaD
Prochlorperazine—Rash—Prednisone—prostate cancer	2.51e-05	0.000268	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisone—prostate cancer	2.51e-05	0.000268	CcSEcCtD
Prochlorperazine—Headache—Prednisone—prostate cancer	2.5e-05	0.000267	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—prostate cancer	2.48e-05	0.000264	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—prostate cancer	2.47e-05	0.000263	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—prostate cancer	2.47e-05	0.000263	CcSEcCtD
Prochlorperazine—Desipramine—CYP2E1—prostate cancer	2.44e-05	0.00905	CrCbGaD
Prochlorperazine—Desipramine—CYP2C19—prostate cancer	2.42e-05	0.00896	CrCbGaD
Prochlorperazine—Clobazam—CYP3A4—prostate cancer	2.42e-05	0.00896	CrCbGaD
Prochlorperazine—Pipotiazine—CYP3A4—prostate cancer	2.42e-05	0.00896	CrCbGaD
Prochlorperazine—Promazine—CYP2C19—prostate cancer	2.34e-05	0.00868	CrCbGaD
Prochlorperazine—Hypersensitivity—Epirubicin—prostate cancer	2.3e-05	0.000245	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—prostate cancer	2.29e-05	0.000245	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—prostate cancer	2.28e-05	0.000243	CcSEcCtD
Prochlorperazine—Clozapine—CYP2E1—prostate cancer	2.21e-05	0.0082	CrCbGaD
Prochlorperazine—Pruritus—Epirubicin—prostate cancer	2.21e-05	0.000235	CcSEcCtD
Prochlorperazine—Clozapine—CYP2C19—prostate cancer	2.19e-05	0.00812	CrCbGaD
Prochlorperazine—Clozapine—CYP1A1—prostate cancer	2.18e-05	0.00809	CrCbGaD
Prochlorperazine—Hypersensitivity—Doxorubicin—prostate cancer	2.13e-05	0.000227	CcSEcCtD
Prochlorperazine—Mianserin—CYP3A4—prostate cancer	2.09e-05	0.00774	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP2E1—prostate cancer	2.08e-05	0.00771	CrCbGaD
Prochlorperazine—Imipramine—CYP2E1—prostate cancer	2.07e-05	0.00767	CrCbGaD
Prochlorperazine—Dizziness—Epirubicin—prostate cancer	2.06e-05	0.00022	CcSEcCtD
Prochlorperazine—Imipramine—CYP2C19—prostate cancer	2.05e-05	0.0076	CrCbGaD
Prochlorperazine—Pruritus—Doxorubicin—prostate cancer	2.04e-05	0.000218	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—prostate cancer	1.97e-05	0.00021	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—prostate cancer	1.96e-05	0.00021	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—prostate cancer	1.95e-05	0.000208	CcSEcCtD
Prochlorperazine—Clomipramine—CYP3A4—prostate cancer	1.91e-05	0.00708	CrCbGaD
Prochlorperazine—Dizziness—Doxorubicin—prostate cancer	1.91e-05	0.000204	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—prostate cancer	1.82e-05	0.000194	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—prostate cancer	1.82e-05	0.000194	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—prostate cancer	1.81e-05	0.000193	CcSEcCtD
Prochlorperazine—Perphenazine—CYP3A4—prostate cancer	1.65e-05	0.00612	CrCbGaD
Prochlorperazine—Quetiapine—CYP3A4—prostate cancer	1.62e-05	0.006	CrCbGaD
Prochlorperazine—Desipramine—CYP3A4—prostate cancer	1.54e-05	0.0057	CrCbGaD
Prochlorperazine—Promazine—CYP3A4—prostate cancer	1.49e-05	0.00552	CrCbGaD
Prochlorperazine—Clozapine—CYP3A4—prostate cancer	1.39e-05	0.00516	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP3A4—prostate cancer	1.31e-05	0.00486	CrCbGaD
Prochlorperazine—Imipramine—CYP3A4—prostate cancer	1.3e-05	0.00483	CrCbGaD
Prochlorperazine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.51e-06	6.67e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IRS1—prostate cancer	2.5e-06	6.63e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGF—prostate cancer	2.5e-06	6.63e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.49e-06	6.62e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—prostate cancer	2.49e-06	6.61e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SERPINE1—prostate cancer	2.49e-06	6.6e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APC—prostate cancer	2.48e-06	6.58e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	2.48e-06	6.58e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—prostate cancer	2.46e-06	6.54e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGF—prostate cancer	2.45e-06	6.51e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IRS1—prostate cancer	2.45e-06	6.51e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	2.44e-06	6.48e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APC—prostate cancer	2.44e-06	6.48e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.43e-06	6.46e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ACHE—prostate cancer	2.43e-06	6.46e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—prostate cancer	2.43e-06	6.45e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GSK3B—prostate cancer	2.42e-06	6.43e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGF—prostate cancer	2.41e-06	6.4e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IRS1—prostate cancer	2.41e-06	6.4e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGF2—prostate cancer	2.41e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.41e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TYMS—prostate cancer	2.4e-06	6.37e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—INS—prostate cancer	2.39e-06	6.35e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GSK3B—prostate cancer	2.38e-06	6.32e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOS3—prostate cancer	2.37e-06	6.31e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1B—prostate cancer	2.37e-06	6.3e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.37e-06	6.3e-05	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—prostate cancer	2.35e-06	6.23e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—INS—prostate cancer	2.35e-06	6.23e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.34e-06	6.22e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CREBBP—prostate cancer	2.34e-06	6.22e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	2.34e-06	6.21e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.33e-06	6.18e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—LPL—prostate cancer	2.33e-06	6.18e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—prostate cancer	2.33e-06	6.17e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—prostate cancer	2.32e-06	6.17e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—prostate cancer	2.31e-06	6.14e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—prostate cancer	2.31e-06	6.13e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—INS—prostate cancer	2.31e-06	6.13e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—JAK2—prostate cancer	2.31e-06	6.13e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.3e-06	6.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—prostate cancer	2.3e-06	6.11e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CREBBP—prostate cancer	2.3e-06	6.1e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—prostate cancer	2.27e-06	6.03e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—prostate cancer	2.26e-06	6.01e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—prostate cancer	2.26e-06	6.01e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	2.26e-06	6e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—prostate cancer	2.26e-06	6e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MDM2—prostate cancer	2.25e-06	5.98e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.25e-06	5.97e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—prostate cancer	2.24e-06	5.95e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	2.23e-06	5.93e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—prostate cancer	2.23e-06	5.93e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.23e-06	5.92e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	2.22e-06	5.9e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB2—prostate cancer	2.22e-06	5.9e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	2.22e-06	5.89e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	2.2e-06	5.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—prostate cancer	2.2e-06	5.83e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.2e-06	5.83e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	2.19e-06	5.83e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	2.19e-06	5.82e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—prostate cancer	2.19e-06	5.82e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1A—prostate cancer	2.19e-06	5.81e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—prostate cancer	2.18e-06	5.8e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	2.18e-06	5.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—prostate cancer	2.17e-06	5.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	2.16e-06	5.73e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	2.16e-06	5.73e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	2.16e-06	5.72e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	2.14e-06	5.69e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—prostate cancer	2.13e-06	5.67e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—prostate cancer	2.13e-06	5.66e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGF2—prostate cancer	2.12e-06	5.64e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	2.12e-06	5.64e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	2.12e-06	5.63e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—prostate cancer	2.11e-06	5.59e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	2.1e-06	5.57e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.1e-06	5.57e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOS3—prostate cancer	2.1e-06	5.57e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.09e-06	5.56e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGF2—prostate cancer	2.09e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EP300—prostate cancer	2.08e-06	5.53e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOS3—prostate cancer	2.06e-06	5.46e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1B—prostate cancer	2.06e-06	5.46e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARA—prostate cancer	2.06e-06	5.46e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGF2—prostate cancer	2.05e-06	5.45e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.05e-06	5.43e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—JAK2—prostate cancer	2.04e-06	5.41e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—prostate cancer	2.03e-06	5.4e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SRC—prostate cancer	2.03e-06	5.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOS3—prostate cancer	2.02e-06	5.38e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NQO1—prostate cancer	2.02e-06	5.37e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—prostate cancer	2.02e-06	5.35e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—prostate cancer	2.01e-06	5.35e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—prostate cancer	2e-06	5.32e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—JAK2—prostate cancer	2e-06	5.31e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	2e-06	5.3e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TH—prostate cancer	1.99e-06	5.3e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MDM2—prostate cancer	1.99e-06	5.28e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—prostate cancer	1.97e-06	5.24e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.97e-06	5.23e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—prostate cancer	1.96e-06	5.21e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.96e-06	5.21e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	1.96e-06	5.2e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—prostate cancer	1.95e-06	5.19e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MDM2—prostate cancer	1.95e-06	5.18e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	1.94e-06	5.16e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.94e-06	5.15e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.93e-06	5.14e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAV1—prostate cancer	1.93e-06	5.13e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.93e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.92e-06	5.11e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.92e-06	5.1e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—prostate cancer	1.91e-06	5.06e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.9e-06	5.04e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	1.9e-06	5.04e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—prostate cancer	1.89e-06	5.03e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.89e-06	5.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GGT1—prostate cancer	1.88e-06	4.99e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.87e-06	4.96e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.86e-06	4.94e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.85e-06	4.91e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—prostate cancer	1.85e-06	4.91e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.83e-06	4.85e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.82e-06	4.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—prostate cancer	1.82e-06	4.82e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.82e-06	4.82e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—prostate cancer	1.81e-06	4.81e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EP300—prostate cancer	1.81e-06	4.8e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.8e-06	4.77e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.8e-06	4.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.78e-06	4.73e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—prostate cancer	1.78e-06	4.72e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—prostate cancer	1.78e-06	4.72e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—prostate cancer	1.78e-06	4.72e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—prostate cancer	1.77e-06	4.69e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.76e-06	4.68e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.76e-06	4.68e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—RXRA—prostate cancer	1.76e-06	4.67e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SRC—prostate cancer	1.76e-06	4.66e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.75e-06	4.66e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.75e-06	4.64e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—prostate cancer	1.74e-06	4.63e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.74e-06	4.61e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.73e-06	4.61e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.73e-06	4.6e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.72e-06	4.56e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.72e-06	4.56e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.71e-06	4.55e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	1.71e-06	4.54e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.71e-06	4.53e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.7e-06	4.52e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—COMT—prostate cancer	1.7e-06	4.5e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—prostate cancer	1.69e-06	4.5e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.69e-06	4.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.68e-06	4.47e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.68e-06	4.46e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—prostate cancer	1.68e-06	4.45e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.68e-06	4.45e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.67e-06	4.44e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.67e-06	4.44e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—INS—prostate cancer	1.67e-06	4.43e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.66e-06	4.41e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.66e-06	4.4e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.65e-06	4.38e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.64e-06	4.37e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.64e-06	4.36e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.63e-06	4.34e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.63e-06	4.33e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.62e-06	4.31e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.62e-06	4.3e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.61e-06	4.29e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.6e-06	4.25e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EP300—prostate cancer	1.59e-06	4.23e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.58e-06	4.18e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.57e-06	4.18e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.57e-06	4.17e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TYMS—prostate cancer	1.57e-06	4.17e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EP300—prostate cancer	1.57e-06	4.16e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.55e-06	4.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SRC—prostate cancer	1.55e-06	4.12e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.55e-06	4.11e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.54e-06	4.09e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.54e-06	4.09e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.54e-06	4.09e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LPL—prostate cancer	1.52e-06	4.04e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SRC—prostate cancer	1.52e-06	4.04e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.51e-06	4.01e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.5e-06	3.98e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.49e-06	3.97e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—prostate cancer	1.49e-06	3.96e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.48e-06	3.94e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.47e-06	3.9e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.47e-06	3.9e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NOS3—prostate cancer	1.46e-06	3.88e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.46e-06	3.87e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.46e-06	3.87e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.45e-06	3.86e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.44e-06	3.84e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—prostate cancer	1.39e-06	3.69e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.39e-06	3.68e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.37e-06	3.64e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—prostate cancer	1.36e-06	3.62e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—prostate cancer	1.36e-06	3.62e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.36e-06	3.61e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.36e-06	3.61e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.35e-06	3.58e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARA—prostate cancer	1.34e-06	3.57e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.34e-06	3.56e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.34e-06	3.56e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.34e-06	3.55e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.34e-06	3.55e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.33e-06	3.54e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.31e-06	3.49e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—prostate cancer	1.29e-06	3.43e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.28e-06	3.41e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAV1—prostate cancer	1.26e-06	3.36e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.26e-06	3.35e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—prostate cancer	1.26e-06	3.34e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.24e-06	3.29e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—prostate cancer	1.18e-06	3.14e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	3.13e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—prostate cancer	1.17e-06	3.1e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.16e-06	3.07e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.15e-06	3.06e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—prostate cancer	1.14e-06	3.03e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.14e-06	3.03e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—prostate cancer	1.12e-06	2.97e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—EP300—prostate cancer	1.11e-06	2.95e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—prostate cancer	1.1e-06	2.93e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.09e-06	2.9e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—INS—prostate cancer	1.09e-06	2.89e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.07e-06	2.83e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—prostate cancer	1.04e-06	2.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—prostate cancer	1.03e-06	2.72e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.01e-06	2.69e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—prostate cancer	1.01e-06	2.68e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—prostate cancer	9.63e-07	2.56e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NOS3—prostate cancer	9.56e-07	2.54e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—prostate cancer	9.46e-07	2.51e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—prostate cancer	9.31e-07	2.47e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.82e-07	2.34e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—prostate cancer	8.74e-07	2.32e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.23e-07	2.18e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—prostate cancer	7.62e-07	2.02e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—EP300—prostate cancer	7.27e-07	1.93e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—prostate cancer	6.72e-07	1.78e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.38e-07	1.43e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—prostate cancer	4.39e-07	1.17e-05	CbGpPWpGaD
